Menzies Research Institute director named HHMI International Research Scholar

July 08, 2005

Menzies Research Institute Director, Professor Simon Foote, has been awarded US$350,000 over five years as a Howard Hughes Medical Institute (HHMI) International Research Scholar to fight the debilitating parasitic disease, malaria.

Professor Foote says it is a great honour to be awarded this international scholarship, with the award providing the Institute the opportunity to further expand its medical research in Tasmania.

"This funding will allow the Menzies Research Institute to expand its genetic research program to include malaria, which is the third most lethal disease globally.

"Malaria infects 250 million people and kills more than two million worldwide each year. With the parasite's increasing resistance to anti-malarial drugs, and mosquito resistance to insecticides, there is a worldwide need for innovative research into malaria," Professor Foote said.

The HHMI International Research Scholar funding will assist Professor Foote to better understand how a person's immune system fights malaria. He will do this by infecting laboratory mice that have rare genetic mutations with malaria, and studying the mutations that allow the animals to survive infection.

"This research will contribute to the global understanding of host response to malaria and lead to the development of new, more effective anti-malarial therapies," he said.

Professor Foote has extensive experience in infectious diseases and parasitology through his work at the Walter and Eliza Hall Institute of Medical Research in Melbourne, where he has a continuing appointment for fifty percent of his time as Joint-Head of the Genetics and Bioinformatics Division until the end of 2005.

The HHMI has awarded US$17.5 million to 42 outstanding scientists in 20 countries to tackle the mysteries of infectious and parasitic disease.

Eight of these scientists are based in Australia, which is more than in any other country. What they learn could help identify potential new drug targets and develop vaccines. Nearly 500 scientists from 62 countries applied for the five-year awards.

The HHMI is a nonprofit medical research organisation, based in the United States of America, dedicated to biomedical research and education. Through their international program, HHMI seeks to support scientists of the highest quality in their home countries. They also bring these international scholars together with each other and with other scientists in the HHMI community annually to create an international network of scientific excellence.
-end-
Professor Simon Foote is available for interview:

Where: Menzies Research Institute, 17 Liverpool Street, Hobart
When: 11.00 am, Friday 8 July

Please note our change of name from Menzies Centre to Menzies Research Institute

For more information contact:
Jill Butterworth
Communications Coordinator
Menzies Research Institute
Phone 61-362-267-751 or 61-409-705-278

Research Australia

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.